Carlsmed

CARL · NASDAQ

$14.18+$0.52 (+3.81%)TodayMarket closed ·
Prev close $13.66

About CARL

Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 127 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.

Employees
127
Headquarters
Carlsbad, California
Listed
Jul 23, 2025
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Carlsmed executives
NameTitleSince
Michael Cordonnier—2018
Niall Casey—2018
Leonard Greenstein——
William Durall——
Jenifer Kamocsay——
Robert Mittendorff——
Kevin O'Boyle——
Jonathan Root——
Kevin Sidow——
Philip Young——

Similar companies

Companies in the same industry as Carlsmed

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.